One shot to lower cholesterol for life? Scientists unlock a groundbreaking gene therapy

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction without altering DNA, offering a potential one-time treatment for high cholesterol.

How fruit fly genetics could change the fight against mosquito diseases

How fruit flies mate may hold a key to limiting the spread of diseases by mosquitoes.

January 25, 2025

Formycon AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: Formycon AG – from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Formycon AG Company Name: Formycon AG ISIN:

June 14, 2024

Eight Capital Analysts Believe Canopy Is Going Down

TerrAscend has had a watershed moment, and Canopy Growth reaches $0 price target. Welcome to our latest Trade to Black podcast. Host Shadd Dales, millennial

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.